Proliferative spasmolytic polypeptide-expressing metaplasia in gastric carcinogenesis: Stem cell origins, lineage plasticity, and clinical implications

Spasmolytic polypeptide-expressing metaplasia (SPEM) is a common, biologically heterogeneous metaplastic phenotype arising in the gastric corpus after oxyntic gland injury.Acute injury-associated SPEM is usually transient and reversible, whereas persistent inflammatory or oncogenic stimulation can result in SPEM with sustained proliferative activity, intestinal differentiation, incomplete intestinal metaplasia, dysplasia, and molecular alterations associated with neoplastic progression.These features identify proliferative SPEM as a progression-associated subset with greater relevance to gastric carcinogenesis.The cellular origin of SPEM remains unresolved and varies among experimental models.Lineage-tracing studies support contributions from corpus isthmus stem/progenitor cells, chief-cell-labeled populations, and the mucous neck-chief transitional lineage.Most of the related lineage-tracing and mechanistic evidence has been derived using mouse models, whereas clinicopathological and molecular associations have been primarily demonstrated via human studies.SPEM is not an obligatory intermediate in gastric carcinogenesis, and its neoplastic potential is linked to particular proliferative metaplastic populations and accompanying stem/progenitor-cell alterations.Reproducible pathological and molecular criteria and prospective human validation are required to establish the value of proliferative SPEM for risk stratification and surveillance.

Authors

Institutions

Publication Details

Journal
World Journal of Stem Cells
Published
2026-11-13
DOI
https://doi.org/10.4252/wjsc.126709
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Proliferative spasmolytic polypeptide-expressing metaplasia in gastric carcinogenesis: Stem cell origins, lineage plasticity, and clinical implications

Yi-Zhong Liang, Xinxin Hong, Shaoju Guo, Yanzi Huang et al.
1 links
World Journal of Stem Cells
Helicobacter pylori-related gastroenterology studies
article

Proliferative spasmolytic polypeptide-expressing metaplasia in gastric carcinogenesis: Stem cell origins, lineage plasticity, and clinical implications

Yi-Zhong Liang, Xinxin Hong, Shaoju Guo, Yanzi Huang, Yong Gao, Xin-Bo Chen, Hui-Shan Yuan, Wei-Jian Zhang, Yi-Fei Xu, Shu-Tong Zheng, Qiang Chen, Hai-Wen Li
article en

Abstract

Spasmolytic polypeptide-expressing metaplasia (SPEM) is a common, biologically heterogeneous metaplastic phenotype arising in the gastric corpus after oxyntic gland injury.Acute injury-associated SPEM is usually transient and reversible, whereas persistent inflammatory or oncogenic stimulation can result in SPEM with sustained proliferative activity, intestinal differentiation, incomplete intestinal metaplasia, dysplasia, and molecular alterations associated with neoplastic progression.These features identify proliferative SPEM as a progression-associated subset with greater relevance to gastric carcinogenesis.The cellular origin of SPEM remains unresolved and varies among experimental models.Lineage-tracing studies support contributions from corpus isthmus stem/progenitor cells, chief-cell-labeled populations, and the mucous neck-chief transitional lineage.Most of the related lineage-tracing and mechanistic evidence has been derived using mouse models, whereas clinicopathological and molecular associations have been primarily demonstrated via human studies.SPEM is not an obligatory intermediate in gastric carcinogenesis, and its neoplastic potential is linked to particular proliferative metaplastic populations and accompanying stem/progenitor-cell alterations.Reproducible pathological and molecular criteria and prospective human validation are required to establish the value of proliferative SPEM for risk stratification and surveillance.

World Journal of Stem Cells
Guangzhou University of Chinese Medicine (CN), Fourth People's Hospital of Shenzhen (CN)
National Natural Science Foundation of China, Guangdong Medical Research Foundation, Sanming Project of Medicine in Shenzhen
Good health and well-being
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon